SCHEMBL28211672

SCHEMBL28211672

O=C(Nc1ccccc1)OC(=O)C(F)(F)F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.47
TSHR P16473 2/20 0.47
TP53 P04637 1/20 0.47
EPHX1 P07099 1/20 0.47
EPHX2 P34913 1/20 0.47
CDK9 P50750 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
PDK1 Q15118 2/20 0.46
PDK2 Q15119 2/20 0.46
PDK3 Q15120 2/20 0.46
PDK4 Q16654 2/20 0.46
HDAC3 O15379 2/20 0.45
HDAC4 P56524 2/20 0.45
HDAC1 Q13547 2/20 0.45
HDAC7 Q8WUI4 2/20 0.45
HDAC2 Q92769 2/20 0.45
HDAC10 Q969S8 2/20 0.45
HDAC11 Q96DB2 2/20 0.45
HDAC8 Q9BY41 2/20 0.45
HDAC6 Q9UBN7 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5153811 0.82 PDK1 (0.49) SMN1; SMN2TSHRPDK1PDK2PDK3
SCHEMBL2244779 0.82 SMN1; SMN2 (0.61) SMN1; SMN2TSHRTP53EPHX1EPHX2
SCHEMBL7450832 0.80 RAB9A (0.51) SMN1; SMN2HDAC3HDAC4HDAC1HDAC7
SCHEMBL10673838 0.79 ALDH1A1 (0.46) SMN1; SMN2TSHRTP53EPHX1EPHX2
Trifluoroacetic Acid SCHEMBL27745571 0.78 SMN1; SMN2 (0.59) SMN1; SMN2TSHRTP53EPHX1EPHX2
SCHEMBL4436187 0.77 PDK1 (0.53) SMN1; SMN2TSHRTP53EPHX1EPHX2
Fluoride SCHEMBL10887137 0.76 PDK1 (0.51) SMN1; SMN2TSHRTP53EPHX1EPHX2
SCHEMBL23240942 0.75 SMN1; SMN2 (0.52) SMN1; SMN2TSHRTP53EPHX1EPHX2
SCHEMBL6002669 0.75 NAPRT (0.59) SMN1; SMN2TSHRTP53EPHX1EPHX2
SCHEMBL9065932 0.75 SMN1; SMN2 (0.52) SMN1; SMN2TSHRTP53EPHX1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240409531-A1 BENZOXAZINONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS MERCK SHARP & DOHME LLC (US) 2024-12-12 US disclosed
CN-107849008-A A kind of octahydro pentamethylene simultaneously [c] azole derivatives and preparation method thereof and purposes in medicine 四川海思科制药有限公司 2018-03-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240409531-A1 BENZOXAZINONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS NFATC1, ACIN1, GZMB SMN1; SMN2 2567/4885TSHR 4793/4885TP53 1434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.